Safe to stop anticoagulants three months after VTE linked to COVID-19, study suggests
Doctors reported fewer than 40 recurrences in the year following discontinuation, among 1100 patients.
Long-term anticoagulation may be unnecessary in patients with COVID-19-associated VTE, with doctors reporting low rates of recurrence after stopping therapy.
Their study of 1100 adults suggests that three months of anticoagulation is sufficient to ward off VTE recurrences.
This was based on fewer than 40 such events occurring in the 12 months after discontinuation.
The Spanish investigators said their findings “can contribute to the decision-making process regarding the optimal duration of anticoagulant treatment” but stressed the need for further research.
